Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 1–15 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2712 4H Syndrome Genetic Sequencing Test This test identifies genetic variants associated with 4H Syndrome, a rare disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism.	Whole Blood	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in POLR3A gene", "Pathogenic variants in POLR3B gene", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of 4H syndrome", "Patients presenting with characteristic features of 4H syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 51961-7 ICD-10: E23.0, G37.8, K00.0 Clinical summary This test identifies genetic variants associated with 4H Syndrome, a rare disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism.
TEST-5892 AASS Gene Saccharopinuria Genetic Test This genetic test identifies pathogenic variants in the AASS gene, which are responsible for causing saccharopinuria, a rare inherited metabolic disorder.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AASS gene", "Single-nucleotide variants", "Insertions/deletions (indels)", "Copy number changes"] Parameters [] Preparation ["Fasting is not mandatory", "Provide a complete list of current medications, supplements, and dietary therapies"] Indications ["Diagnostic workup for suspected saccharopinuria", "Carrier screening for family members", "Prenatal planning guidance"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E72.3 Clinical summary This genetic test identifies pathogenic variants in the AASS gene, which are responsible for causing saccharopinuria, a rare inherited metabolic disorder.
TEST-6100 ABCB4 Gene (Intrahepatic Cholestasis of Pregnancy Type 3) Next‑Generation Sequencing (Genetic Test This genetic test analyzes the ABCB4 gene for pathogenic variants causing intrahepatic cholestasis of pregnancy type 3 (ICP3). It detects single nucleotide variants, small insertio...	Whole Blood (Peripheral Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCB4 gene pathogenic variants", "Single nucleotide variants", "Small insertions or deletions", "Copy-number variations"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by your doctor"] Indications ["Pregnant women with unexplained pruritus and elevated bile acids", "Individuals with a family history of severe ICP or early-onset disease", "Genetic counselling prior to testing is mandatory"] Measurement technique Confirm with laboratory Codes LOINC: 21671-4 ICD-10: O26.619 Clinical summary This genetic test analyzes the ABCB4 gene for pathogenic variants causing intrahepatic cholestasis of pregnancy type 3 (ICP3). It detects single nucleotide variants, small insertions/deletions, and copy-number variations across the entire coding region.
TEST-5272 ACTA1 Gene Myopathy (Scapulohumeroperoneal) Genetic Test This genetic test identifies mutations in the ACTA1 gene associated with autosomal dominant scapulohumeroperoneal myopathy.	Peripheral whole blood (EDTA tube, 4 ml)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTA1 gene mutations", "Point mutations", "Small insertions/deletions", "Splice-site variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected scapulohumeroperoneal myopathy", "Family history of myopathy", "Congenital neuromuscular disorder"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.2 Clinical summary This genetic test identifies mutations in the ACTA1 gene associated with autosomal dominant scapulohumeroperoneal myopathy.
TEST-4909 AICDA Gene (Immunodeficiency with Hyper-IgM Type 2) Genetic Test This test evaluates the AICDA gene for pathogenic variants associated with Hyper-IgM syndrome type 2, a primary immunodeficiency.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AICDA gene", "Copy-number variants in the AICDA gene"] Parameters [] Preparation ["Genetic counselling session required", "Provide complete clinical history", "Report bleeding disorders or anticoagulant use"] Indications ["Suspected Hyper-IgM syndrome type 2", "Evaluation of primary immunodeficiency", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 55176-5 ICD-10: D80.5 Clinical summary This test evaluates the AICDA gene for pathogenic variants associated with Hyper-IgM syndrome type 2, a primary immunodeficiency.
TEST-3436 AKR1C4 Gene Sequencing (46,XY Sex Reversal Type 8 Modifier) Test This test evaluates the AKR1C4 gene for pathogenic variants associated with 46,XY sex reversal type 8.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AKR1C4 gene sequence", "Pathogenic variants in coding exons and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of 46,XY sex reversal type 8", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E25.8, Q56.1 Clinical summary This test evaluates the AKR1C4 gene for pathogenic variants associated with 46,XY sex reversal type 8.
TEST-2607 AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test This genetic test identifies pathogenic variants in the AKT3 gene associated with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 (MPPH2).	Peripheral Whole Blood (2–3 mL, EDTA tube or DNA FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AKT3 gene", "Coding exons ±20 bp splice sites of AKT3"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Infants and children with clinical or MRI features of MPPH2", "Suspected AKT3-related disorder"] Measurement technique Confirm with laboratory Codes LOINC: 21636-2 ICD-10: Q04.8 Clinical summary This genetic test identifies pathogenic variants in the AKT3 gene associated with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 (MPPH2).
TEST-5877 ALDH5A1 Gene Succinic Semialdehyde Dehydrogenase Deficiency Genetic Test This genetic test identifies mutations in the ALDH5A1 gene responsible for succinic semialdehyde dehydrogenase (SSADH) deficiency.	Peripheral whole blood (EDTA tube)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALDH5A1 gene mutations", "Single nucleotide variants", "Small indels", "Exon-level copy number changes"] Parameters [] Preparation ["No special preparation such as fasting is required."] Indications ["Suspected SSADH deficiency based on clinical presentation", "Confirmation of diagnosis", "Family planning for autosomal recessive disorders"] Measurement technique Confirm with laboratory Codes LOINC: 90521-1 ICD-10: E72.8 Clinical summary This genetic test identifies mutations in the ALDH5A1 gene responsible for succinic semialdehyde dehydrogenase (SSADH) deficiency.
TEST-6309 ALG8 Gene (Congenital Disorder of Glycosylation Type Ih) Genetic Test This genetic test identifies inherited mutations in the ALG8 gene associated with Congenital Disorder of Glycosylation Type Ih (CDG-1h).	Whole Blood (Venipuncture or FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALG8 gene", "Glycoprotein synthesis pathway defects"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "Document a three-generation pedigree."] Indications ["Suspected Congenital Disorder of Glycosylation Type Ih (CDG-1h)", "Family history of CDG-1h", "Unexplained multi-systemic symptoms suggestive of a metabolic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 96021-5 ICD-10: E74.8, Z13.79, Z15.89 Clinical summary This genetic test identifies inherited mutations in the ALG8 gene associated with Congenital Disorder of Glycosylation Type Ih (CDG-1h).
TEST-5504 ALX4 Gene Parietal Foramina Type 2 Genetic Test This genetic test evaluates the ALX4 gene for pathogenic mutations associated with parietal foramina type 2 (PFM2).	Whole blood (EDTA), extracted genomic DNA, or dried blood spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALX4 gene coding region", "ALX4 gene splice sites"] Parameters [] Preparation [] Indications ["Definitive diagnosis of PFM2", "Family screening", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q75.8 Clinical summary This genetic test evaluates the ALX4 gene for pathogenic mutations associated with parietal foramina type 2 (PFM2).
TEST-4786 AP1S1 Gene MEDNIK Syndrome Genetic Test This test detects pathogenic variants in the AP1S1 gene associated with MEDNIK syndrome.	Whole blood (EDTA tube) or buccal swab	3–4 Weeks (Expedited)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AP1S1 gene variants", "Disease-causing mutations"] Parameters [{"name": "Diagnostic Sensitivity (SNVs & indels)", "reference_range": ">99.5%"}, {"name": "Diagnostic Sensitivity (CNVs)", "reference_range": "~95%"}, {"name": "Methodology", "reference_range": "NGS (Targeted Gene Sequencing) with deletion/duplication analysis, Sanger confirmation"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected MEDNIK syndrome", "Patients with hallmark signs of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 78126-8 ICD-10: Q87.8 Clinical summary This test detects pathogenic variants in the AP1S1 gene associated with MEDNIK syndrome.
TEST-6132 APOA1 Gene Hypoalphalipoproteinemia Genetic Test This genetic test identifies pathogenic variants in the APOA1 gene associated with primary hypoalphalipoproteinemia.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Dried Blood Spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOA1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting required"] Indications ["Diagnosis of primary hypoalphalipoproteinemia", "Family screening for APOA1 variants", "Personalized cardiovascular risk management"] Measurement technique Confirm with laboratory Codes LOINC: 93977-2 ICD-10: E78.6 Clinical summary This genetic test identifies pathogenic variants in the APOA1 gene associated with primary hypoalphalipoproteinemia.
TEST-3205 APOE Gene Analysis for Sea-Blue Histiocyte Disease (Genetic Test) This test evaluates the entire APOE gene for pathogenic mutations linked to Sea-Blue Histiocyte Disease.	Peripheral Whole Blood (FTA card or venous draw)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE gene sequence", "Pathogenic mutations", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Sea-Blue Histiocyte Disease", "Family history of lipid storage disorders", "Need for genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21605-8 ICD-10: E75.89 Clinical summary This test evaluates the entire APOE gene for pathogenic mutations linked to Sea-Blue Histiocyte Disease.
TEST-3860 APTX Gene Ataxia-Oculomotor Apraxia Type 1 (AOA1) Genetic Test This genetic test evaluates the APTX gene for pathogenic variants associated with Ataxia-Oculomotor Apraxia Type 1 (AOA1). It identifies single-nucleotide variants, small insertion...	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APTX gene", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number alterations"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% — full gene coverage including intron-exon boundaries"}, {"name": "Methodology", "reference_range": "NGS with LC-MS/MS-validated library preparation"}, {"name": "Turnaround Time", "reference_range": "3 to 4 Weeks"}] Preparation ["No fasting required", "Pre-test genetic counselling session is mandatory"] Indications ["Individuals presenting with progressive cerebellar ataxia, oculomotor apraxia, and peripheral neuropathy", "Suspicion of Ataxia-Oculomotor Apraxia Type 1 (AOA1)"] Measurement technique Confirm with laboratory Codes LOINC: 82932-1 ICD-10: G11.3 Clinical summary This genetic test evaluates the APTX gene for pathogenic variants associated with Ataxia-Oculomotor Apraxia Type 1 (AOA1). It identifies single-nucleotide variants, small insertions/deletions, and copy-number variations.
TEST-3847 AQP2 Gene (Nephrogenic Diabetes Insipidus, Autosomal) Genetic Test This test identifies genetic mutations in the AQP2 gene associated with hereditary nephrogenic diabetes insipidus.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AQP2 gene", "Presence of mutations causing nephrogenic diabetes insipidus"] Parameters [] Preparation ["No specific fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected hereditary nephrogenic diabetes insipidus", "Congenital polyuria and polydipsia", "Family history of nephrogenic diabetes insipidus"] Measurement technique Confirm with laboratory Codes LOINC: 90219-3 ICD-10: N25.1 Clinical summary This test identifies genetic mutations in the AQP2 gene associated with hereditary nephrogenic diabetes insipidus.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.